Nuvation Bio Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Nuvation Bio Inc. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $0.00.
- Nuvation Bio Inc. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $0.00.
- Nuvation Bio Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $0.00.
- Nuvation Bio Inc. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $0.00.
- Nuvation Bio Inc. stock issued during period, value, new issues for fiscal 2022 was $0.00.
- Nuvation Bio Inc. stock issued during period, value, new issues for fiscal 2021 was -$3.79M, a 102.79% decline from fiscal 2020.
- Nuvation Bio Inc. stock issued during period, value, new issues for fiscal 2020 was $135.66M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$3.79M 10-K · filed 2023-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | |
| 2021-03-31 | -$3.79M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $135.66M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |